Statement Of Cash Flows [Abstract]

GenSight Biologics S.A. - Filing #2813015

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
27,625,000 EUR
27,625,000 EUR
28,617,000 EUR
28,617,000 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in trade accounts receivable
756,000 EUR
698,000 EUR
Adjustments for decrease (increase) in other operating receivables
5,760,000 EUR
1,287,000 EUR
Adjustments for increase (decrease) in trade accounts payable
2,152,000 EUR
2,398,000 EUR
Adjustments for depreciation and amortisation expense
1,061,000 EUR
928,000 EUR
Adjustments for provisions
30,000 EUR
18,000 EUR
Adjustments for share-based payments
3,364,000 EUR
4,834,000 EUR
Other adjustments for non-cash items
0 EUR
- EUR
Cash flows from (used in) operating activities
33,753,000 EUR
17,139,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
252,000 EUR
32,000 EUR
Purchase of intangible assets, classified as investing activities
0 EUR
EUR
Cash flows from (used in) investing activities
172,000 EUR
16,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
1,000 EUR
28,094,000 EUR
Payments to acquire or redeem entity's shares
193,000 EUR
Proceeds from borrowings, classified as financing activities
10,800,000 EUR
EUR
Repayments of borrowings, classified as financing activities
7,822,000 EUR
3,069,000 EUR
Payments of lease liabilities, classified as financing activities
860,000 EUR
584,000 EUR
Interest paid, classified as financing activities
1,867,000 EUR
835,000 EUR
Cash flows from (used in) financing activities
95,000 EUR
23,739,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
33,487,000 EUR
6,584,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
193,000 EUR
238,000 EUR
Cash and cash equivalents
10,610,000 EUR
44,288,000 EUR
37,943,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.